Title
Viral intra-host evolution in immunocompetent children contributes to human norovirus diversification at the global scale
Date Issued
01 January 2021
Access level
open access
Resource Type
journal article
Author(s)
Tohma K.
Lepore C.J.
Ford-Siltz L.A.
Parra G.I.
Tohoku University Graduate School of Medicine
Johns Hopkins University Bloomberg School of Public Health
Publisher(s)
Taylor and Francis Ltd.
Abstract
Norovirus is a major cause of acute gastroenteritis. Human noroviruses present >30 different genotypes, with a single genotype (GII.4) predominating worldwide. Concurrent outbreaks of norovirus are often associated with the emergence of new viruses. While different hypotheses have been presented, the source of new mutations in noroviruses is still unknown. In this study, we applied high-resolution sequencing to determine the intra-host viral diversity presented by noroviruses during the acute and shedding phase of infection in children. Profiling viral intra-host diversification at nearly full genome level indicated that GII.4 viruses presented dynamic intra-host variation, while non-GII.4 viruses presented minimal variation throughout the infection. Notably, the intra-host genetic variation during the shedding phase recapitulates the genetic diversity observed at the global level, particularly those mapping at the VP1 antigenic sites. Thus the intra-host evolution in healthy children explains the source of norovirus mutations that results in diversification at the global scale.
Start page
1717
End page
1730
Volume
10
Issue
1
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Gastroenterología, Hepatología
Subjects
Scopus EID
2-s2.0-85114357886
PubMed ID
Source
Emerging Microbes and Infections
ISSN of the container
22221751
Sponsor(s)
Financial support for this work was provided by the Food and Drug Administration intramural funds [Program Number Z01 BK 04012 LHV to G.I.P] and National Institute of Allergy and Infectious Diseases fund (R01 AI 108695 and R21 AI 099737 to R.H.G). K.T. and C.J.L. were recipients of a CBER/FDA-sponsored Oak Ridge Institute for Science and Education (ORISE) fellowship. The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication. We thank the Facility for Biotechnology Resources at U.S. FDA for their support with next-generation sequencing. We thank the community of San Juan de Miraflores and Villa El Salvador for their collaboration and Asociación Benéfica PRISMA for the fieldwork in Peru.
Sources of information:
Directorio de Producción Científica
Scopus